Category: Edwards LifesciencesSyndicate content

ACC 2015 Roundup: CTA no benefit, Abbott's MitraClip, Philips' IntelliSpace

March 16, 2015 by Brad Perriello

Screening coronary artery disease patients using computed-tomography angiography is no better than functional testing in improving outcomes, according to a large clinical study by the National Heart, Lung & Blood Institute, plus more from the annual meeting of the American College of Cardiology.

ACC 2015 Roundup: CTA no benefit, Abbott's MitraClip, Philips' IntelliSpace

A large clinical trial comparing computed-tomography angiography with functional testing found no benefit to clinical outcomes with CTA, which also exposes patients to large doses of radiation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ACC 2015: Danish study finds TAVI safe for low-risk patients

March 16, 2015 by MassDevice

A Danish study presented at the American College of Cardiology's annual conference shows that transcatheter aortic valve implants are safe in low-risk patients.

ACC 2015: Danish study finds TAVI safe for low-risk patients

(Reuters) — Transcatheter aortic valve implantation is safe for low-risk patients, according to a study presented at the American College of Cardiology meeting in San Diego.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TAVI: Strong results for heart valves from Edwards Lifesciences, Medtronic

March 16, 2015 by Brad Perriello

Replacement heart valves made by Edwards Lifesciences and Medtronic once again dominate the American College of Cardiology's annual meeting, with long-term results for Edwards' Sapien and Medtronic's CoreValve complemented by even better data from their next-generation transcatheter aortic valve implants.

TAVI: Strong results for heart valves from Edwards Lifesciences, Medtronic

Transcatheter aortic valve implants once again took the spotlight at the annual meeting of the American College of Cardiology, with a spate of studies both confirming the long-term benefits of the replacement heart valves and showing that newer TAVI versions are even better.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech's $33m lobbying spend last year hits 16-year high

March 9, 2015 by Brad Perriello

The lobbying spend in Washington hit a 16-year high of nearly $33 million in 2014, as the industry continued its fight to repeal Obamacare's medical device tax.

Medtech's $33m lobbying spend is an all-time high

The medical device industry's lobbying spend hit its highest point since 1998 last year, nearing $33 million, as the industry stepped up its campaign to repeal the medical device tax enacted as part of Obamacare.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

SEMDA taps AdvaMed's Jason Rupp for executive director role |Personnel Moves

February 18, 2015 by Brian Johnson

Jason Rupp, former AdvaMed executive is named executive director for Southeastern Medical Device Association (SEMDA).

JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

The Southeastern Medical Device Association (SEMDA) has named former AdvaMed executive Jason Rupp as its first full time executive director.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Edwards CFO Ullem: Share buybacks more likely than M&A

February 4, 2015 by Brian Johnson

Edwards Lifesciences is flush with cash after a solid 2014, but is more likely to spend on share buybacks than acquisitions, CFO Scott Ullem tells analysts.

Edwards CFO Ullem: Share buybacks more likely than M&A

Edwards Lifesciences raises outlook after Q4 profits soar

February 4, 2015 by MassDevice

Edwards Lifesciences boosts its outlook for 2015 after reporting soaring profits for the 4th quarter.

Edwards Lifesciences raises outlook after Q4 profits soar

Get the complete picture with a MassDevice Plus membership. Registered users can login here.